Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dodecanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 5/20 | 0.54 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.43 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodecanol SCHEMBL31116708 | 1.00 | GRIK1 (0.54) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| Aspartic Acid SCHEMBL2213924 | 1.00 | GRIK1 (0.54) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| Dodecanol SCHEMBL31116714 | 0.98 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| Aspartic Acid SCHEMBL7158842 | 0.86 | GRIK1 (0.50) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| Palmitic Acid SCHEMBL30579949 | 0.85 | GPR84 (0.63) | GRIK1GRIK2LMNAALDH1A1TSHR | |
| Octadecylamine SCHEMBL28985934 | 0.85 | GRIK1 (0.54) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| Palmitic Acid SCHEMBL22635743 | 0.85 | GPR84 (0.63) | GRIK1GRIK2LMNAALDH1A1TSHR | |
| Dodecanoate SCHEMBL31258580 | 0.85 | GPR84 (0.63) | GRIK1GRIK2LMNAALDH1A1TSHR | |
| Dodecanol SCHEMBL30392850 | 0.85 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| Cetostearyl Alcohol SCHEMBL27937331 | 0.85 | GRIK1 (0.53) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130245246-A1 | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE | ADOCIA (FR) | 2013-09-19 | — | — | US | disclosed |
| US-20110178011-A1 | Polysaccharide/BMP complexes which are soluble at physiological pH | ADOCIA (FR) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130245246-A1 | POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE | CD44, B3GAT3, UGCG | GRIK1 1714/4885GRIK2 1352/4885SLC1A2 2708/4885 |
| US-20110178011-A1 | Polysaccharide/BMP complexes which are soluble at physiological pH | BMP1, BMP2, BMP6 | GRIK1 4295/4885GRIK2 4017/4885SLC1A2 4300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.